Respiratory syncytial virus vaccine (AlphaVax/Novartis)

N/A

Report date: 2025/02/11 10:46:16

Base Information

Drug NameRespiratory syncytial virus vaccine (AlphaVax/Novartis)
Drug Alias NameRSV vaccine (AlphaVax)RSV-F vaccine (AlphaVax)
ClassificationVaccines > Biological material > Viral vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsRespiratory Syncytial Virus Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAlphavax Inc
China Registration ClassN/A

Develop Information

Active CompaniesAlphavax Inc
Inactive CompaniesN/A
Active IndicationsRespiratory Syncytial Virus Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A